The neuroprotective drugs development company announces today the appointment of two former Vice Presidents of Sanofi - Aventis; Bernard Reculeau, and Jesús Benavides.
Bernard has a 25 years experience in pharmaceutical and biotechnology industry.
Up to 2009, he was CEO of CISBIO, a french biotech company
now acquired by IBA group. Up to 2005, Bernard was Senior Vice President
Pharmaceutical Operations at Sanofi-Aventis, and from 1996 to 2004, he was
Senior Vice President and General Manager Aventis Pharma International.
NEUROKIN is glad to benefit from Bernard's unique experience in big Pharma
as well as in biotech companies.
